[Form 3] XBiotech Inc. Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

Initial Form 3 filed for XBiotech Inc. (XBIT) by David Soffer, who identifies his relationship to the issuer as a director. The filing states that the reporting person does not beneficially own any securities of the issuer. The Form 3 is an initial Section 16 filing that discloses current ownership; in this case there are no non-derivative or derivative holdings reported.

Positive

• Form 3 filed indicating compliance with Section 16 disclosure requirements

Negative

• Reporting director holds no beneficial securities of XBiotech as disclosed on the Form 3

Insights

Financial Analyst

TL;DR: Director filed an initial ownership statement and reports zero beneficial holdings in XBIT, yielding neutral market impact.

The Form 3 confirms compliance with Section 16 reporting but discloses no ownership stake by the reporting director. From an investor-return perspective, this filing does not provide revenue, earnings, or transactional information and is not material to valuation models. The absence of a director stake may be noted for governance considerations, but it does not alter near-term financial expectations based solely on this filing.

Corporate Governance Expert

TL;DR: Governance disclosure completed; lack of director ownership is a governance data point, not a material event by itself.

The filing functions as an initial disclosure of potential insider status and shows the reporting person is a director with no beneficially owned securities. This is a factual governance disclosure that could be referenced when assessing director alignment with shareholder interests, but the document contains no transactions, grants, or pledges that would have immediate governance or control implications.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Soffer David Spencer

(Last) (First) (Middle)

1910 SOMMERFELD AVE

(Street)

SASKATOON A9 S7J 2E3

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/29/2025

3. Issuer Name and Ticker or Trading Symbol
XBiotech Inc. [ XBIT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	David Soffer	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 3 filed for XBiotech (XBIT) disclose?

The Form 3 filed by David Soffer discloses that he is a director of XBiotech and does not beneficially own any securities of the issuer.

Does the Form 3 report any stock or option holdings for the reporting person?

No. The filing explicitly states no securities are beneficially owned, and no non-derivative or derivative holdings are listed.

Is this Form 3 an initial or amended filing for XBiotech (XBIT)?

This document is presented as an initial statement of beneficial ownership (Form 3) for the reporting person.

Does the Form 3 include any transactions or grants involving XBiotech securities?

No. The filing contains no transactions, grants, exercises, or other derivative instruments.

What relationship to the issuer does the reporting person have according to the filing?

The filing identifies David Soffer as a director of XBiotech.